Unlock Neuroprotective Potential:Pharma-Grade Curcumin for Alzheimer’s Disease & Cognitive Formulations
Alzheimer’s disease (AD) remains a criticalunmet medical need, driving demand for multi-target neuroprotective agents.Blue Eyes Biotech supplies high-purity Curcumin (>95%) – a potent naturalcompound validated in preclinical AD models to:
- Inhibit pathological Tau phosphorylationvia GSK-3β/CDK5 modulation
- Suppress neuroinflammation throughmicroglia-mediated NF-κB/TLR4 downregulation
- Rescue synaptic plasticity deficits anddelay cognitive decline
Mechanism-Backed Applications:
Pharmaceuticals: Disease-modifying ADdrugs targeting Tau aggregation
Nutraceuticals: Cognitive healthsupplements with Synapsin I protection
Cosmeceuticals: Neurocosmetic serumscombating brain-skin inflammation
Why Partner with Blue Eyes Biotech?
✅ Bioactivity Validated: Third-partystudies confirm 63% reduction in p-Tau levels & 41% cognitive improvementin AD models
✅ Enhanced Bioavailability: β-cyclodextrincomplexed or nanoparticle formats (10x absorption vs. standard)
✅ Supply Chain Excellence: ISO 9001/GMPmanufacturing | Batch-to-batch consistency
✅ Regulatory Ready: DMF files, USP/EPcompliance, Kosher/Halal
Technical Differentiation:
• Dual-PathwayEfficacy: Simultaneously targets Tau pathology AND neuroinflammation
•Thermo-Stable Formulations: Ideal for tablets, capsules, and topicalneurocosmetics
• SynergisticBlends: Combines with resveratrol, apoaequorin, or phosphatidylserine
For R&D Teams Developing:
→Disease-modifying Alzheimer’s therapeutics
→ Cognitivedecline prevention nutraceuticals
→Neuroprotective anti-aging skincare
Access Science-Backed CurcuminSolutions:
Download preclinical studysummaries
Request custom formulation support
Get Free Samples & TechnicalDossier:
Email: [email protected]
Product Page: www.blueeyes-bio.com